-
Advanced pharmacokinetics and pharmacodynamics for phase Ib/IIa trial of repurposed enoxacin therapy for patients with ALS
https://braincanada.ca/fr/subventions-financées/advanced-pharmacokinetics-and-pharmacodynamics-for-phase-ib-iia-trial-of-repurposed-enoxacin-therapy-for-patients-with-alsAmyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, primarily affecting motor neurons, for which there are currently no adequately effective therapies. Project Overview Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, primarily affecting...
-
Advancing biology based therapies for rhabdoid brain tumours
https://braincanada.ca/fr/subventions-financées/advancing-biology-based-therapies-for-rhabdoid-brain-tumoursRhabdoid brain tumours are the most common brain cancers in infants. Project Overview Rhabdoid brain tumours are the most common brain cancers in infants. Usually these aggressive tumours are treated with intense chemotherapy and radiation therapy, which can have serious side effects. Dr Annie...
-
Advancing Brain Research Through Spatial Histology
https://braincanada.ca/fr/subventions-financées/advancing-brain-research-through-spatial-histologyThe Histology Innovation Platform at McGill University is a specialized facility that helps scientists study the brain at a cellular level to better understand neurological diseases like Alzheimer’s, brain cancer, and epilepsy. Project Overview The Histology Innovation Platform at McGill...
-
Aerobic exercise for treatment of Chronic symptoms following mild Traumatic Brain Injury (ACTBI) Trial
https://braincanada.ca/fr/subventions-financées/aerobic-exercise-for-treatment-of-chronic-symptoms-following-mild-traumatic-brain-injury-actbi-trialAnnually, approximately 250,000 people in Canada sustain a concussion. Project Overview Annually, approximately 250,000 people in Canada sustain a concussion. While symptoms following concussion generally improve within 3 months, up to 30% of people continue to have symptoms beyond this time....
-
AGA de Brain Canada 2022 : Sortir de l'ombre
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/brain-canada-2022-agm-sort-de-l-ombre -
AID-ME: Artificial Intelligence in Depression – Medication Enhancement: A Randomized, Patient and Rater Blinded, Active-Controlled Trial of a DeepLearning Enabled Clinical Decision Aid for Personalized Depression Treatment Selection
https://braincanada.ca/fr/subventions-financées/aid-me-artificial-intelligence-in-depression-medication-enhancement-a-randomized-patient-and-rater-blinded-active-controlled-trial-of-a-deeplearning-enabled-clinical-decision-aid-for-personalized-depression-treatment-selectionWe are testing a new digital mental health solution for physicians to better manage the treatment of depression. Project Overview We are testing a new digital mental health solution for physicians to better manage the treatment of depression. While many treatment options for depression are...
-
Aide aux enfants souffrant de lésions cérébrales
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/aide-aux-enfants-souffrant-de-lésions-cérébralesLe Dr Freda Miller étudie les lésions cérébrales chez les enfants C'était au début de l'année 2010, et l'équipe de recherche du laboratoire du Dr Freda Miller à l'Hospital for Sick Children venait de faire une découverte passionnante : elle avait identifié une voie cruciale pour indiquer aux...
-
Alléger le fardeau des soins de santé - un protocole à la fois
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/alléger-le-fardeau-des-soins-de-santé-un-protocole-à-la-foisLe scanner IRM portable avec lequel le Dr Kolind et son équipe travaillent pour suivre l'évolution de la sclérose en plaques peut être contrôlé à l'aide d'un smartphone. Je m'appelle Alison et je suis la responsable de l'évaluation et des projets spéciaux de Brain Canada. Mon rôle consiste à...
-
ALS Canada et Brain Canada investissent plus d'un demi-million de dollars dans l'avenir des chercheurs en SLA avec les bourses de recherche clinique et les bourses de stagiaire 2023
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/als-canada-et-brain-canada-investissent-plus-d-un-demi-million-de-dollars-dans-l-avenir-des-chercheurs-en-als-avec-les-bourses-de-recherche-clinique-et-les-bourses-de-stagiaire-2023À l'occasion de la Journée mondiale de la science, les dernières bourses de recherche SLA Canada-Cerveau Canada, avec le soutien de la Fondation Vincent Bourque, soulignent l'importance de financer les chercheurs et les cliniciens en début de carrière. À l'occasion de la Journée mondiale de la...
-
Alternative Strategies to Prevent Oral Pathogens Infection and Battle Alzheimer’s Disease
https://braincanada.ca/fr/subventions-financées/alternative-strategies-to-prevent-oral-pathogens-infection-and-battle-alzheimer-s-diseaseProject Overview Bacteria involved in gum disease can be found in the brains of people with Alzheimer’s disease and dementia. These bacteria help release toxins into different tissues, including the brain. And these toxins, in turn, increase amyloid beta in the brain, contributing to Alzheimer’s...